Early Ageing During Therapy in AYA Cancer Patients
Recruiting · NCT05062707 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Medical Center Groningen
View the official record on ClinicalTrials.gov →Interventions studied
Blood sampling
What this trial is about
Longitudinal cohort study; measurements before start of systemic therapy and one year later.
Who can take part
Age range
18 Years to 39 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Aged 18-39 years at cancer diagnosis
- Having a histologically and/or cytologically confirmed cancer diagnosis, including leukemia, (non-)Hodgkin lymphoma, testicular cancer, osteosarcoma, Ewing sarcoma, breast cancer, and cervical cancer.
- Scheduled to start systemic therapy with curative intent. Allowed treatments (concurrent or sequential) are: surgery, radiotherapy, chemotherapy, antibodies.
Exclusion criteria
- patients who are not able to understand the patient information letter and informed consent form
- patients who will be treated with immune checkpoint inhibitors or targeted therapy with inhibitors of angiogenesis
- patients who have been treated with systemic therapy or radiotherapy for a previous malignancy (exceptions: in situ carcinoma of the cervix or uterus and adequately treated basal and squamous cell carcinoma of the skin).
Where it is running
1 location listed.
- University Medical Center Groningen - Groningen, Netherlands